bisantrene has been researched along with Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Z; Deng, X; Dong, L; Fathi, AT; Gao, L; Gao, M; Han, L; Horne, D; Huang, H; Huang, Y; Kulkarni, P; Li, C; Li, H; Li, L; Li, W; Li, Y; Li, Z; Marcucci, G; Mulloy, JC; Müschen, M; Olsen, MJ; Prince, E; Qin, H; Qin, X; Qing, Y; Robinson, S; Salgia, R; Shen, C; Su, R; Sun, J; Tan, B; Wei, M; Weng, H; Wu, X; Wunderlich, M; Xie, J; Zhang, B; Zhao, Z | 1 |
| Hu, GQ; Ji, BS; Xie, SQ; Xu, M; Zhang, ZQ | 1 |
| Donehower, M; Gerad, H; Pocelinko, R; Van Echo, DA; Wiernik, PH | 1 |
| Coltman, CA; Cowan, J; Dahlberg, S; Gumbart, CH; Hussein, K; Mills, GM; Neilan, BA | 1 |
| Hammond, GD; Krailo, MD; Krivit, WA; Movassaghi, N | 1 |
1 trial(s) available for bisantrene and Leukemia
| Article | Year |
|---|---|
Phase I/II study of bisantrene in childhood cancer: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Anthracenes; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Infant; Leukemia; Male | 1988 |
4 other study(ies) available for bisantrene and Leukemia
| Article | Year |
|---|---|
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Anthracenes; Biphenyl Compounds; Cell Line, Tumor; Cell Self Renewal; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Immune Evasion; Leukemia; Membrane Glycoproteins; Molecular Structure; Protein Binding; Protein Domains; Receptors, Immunologic; U937 Cells | 2020 |
Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspases; Cell Line, Tumor; Cytochromes c; Disease Models, Animal; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation; Humans; K562 Cells; Leukemia; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred ICR | 2008 |
Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Anthracenes; Digestive System; Drug Evaluation; Female; Heart Failure; Humans; Hypotension; Leukemia; Leukemia, Lymphoid; Liver; Male; Middle Aged | 1984 |
Phase II evaluation of bisantrene in acute leukemia. A Southwest Oncology Group Study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Remission Induction | 1989 |